FDA Adverse Event Injury Summary report: N

COOK MEDICAL CELECT VENA CAVA FILTER

MDR report key: 13579454 · Received February 18, 2022

Report

Report Number
MW5107597
Event Type
Injury
Date Received
February 18, 2022
Date of Event
February 20, 2020
Report Date
June 6, 2022
Manufacturer
COOK MEDICAL LLC.
Product Code
DTK
Adverse Event
Yes
Product Problem
Yes
Report Source
Voluntary report
Reporter Location
SC, US
Reporter Occupation
PATIENT
Health Professional
*

Narratives

Description of Event or Problem · 0

(B)(6). (15 TYPEWRITTEN PAGES--FAR EXCEEDS 4000 CHARACTERS). FDA SAFETY REPORT ID# (B)(4).

Description of Event or Problem · 0

(B)(6). (15 TYPEWRITTEN PAGES--FAR EXCEEDS 4000 CHARACTERS). FDA SAFETY REPORT ID# (B)(4).

Description of Event or Problem · 0

ADDITIONAL INFORMATION RECEIVED FROM REPORTER FOR REPORT NUMBER MW5107597. REPORTER CALLING TO PROVIDE FURTHER INFORMATION ON A REPORT PREVIOUSLY SUBMITTED, INCLUDING EXPLANT DATE. HE STATES THAT ON 20-FEB-2020, HE WOKE UP WITH DIFFICULTY BREATHING; AFTER SEEING HIS DOCTOR'S OFFICE THE SAME DAY IT WAS DETERMINED HE HAD BILATERAL PULMONARY EMBOLISM. OF NOTE, REPORTER STATES TWO DAYS PRIOR, ON 18-FEB-2020, HE HAD A CT SCAN THAT SHOWED HIS BLOOD CLOT HAD SUBSTANTIALLY GROWN IN SIZE. WHEN HE WENT TO THE HOSPITAL ON 20-FEB-2020, REPORTER STATES HIS LOCAL HOSPITAL WAS UNABLE TO TREAT THE SERIOUSNESS OF HIS CONDITION, SO HE WAS TRANSFERRED TO A LARGER MEDICAL FACILITY. ON 21-FEB-2020, HAD EKOS PROCEDURE TO REMOVE BLOOD CLOTS; HE CREDITS THIS PROCEDURE WITH SAVING HIS LIFE. HE STATES THIS DEVICE WAS EXPLANTED ON (B)(6) 2022. HE IS FILING THIS REPORT WITH THE FDA BECAUSE HE IS UNSURE IF HIS LOCAL HOSPITAL EVER SUBMITTED A REPORT REGARDING THIS ADVERSE EVENT. HE STATES HE HAS ALSO REPORTED THIS ADVERSE EVENT TO THE DEVICE MANUFACTURER, COOK MEDICAL LLC. (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
882369 COOK MEDICAL CELECT VENA CAVA FILTER FILTER, INTRAVASCULAR, CARDIOVASCULAR DTK COOK MEDICAL LLC. G34505 E3901455

Patients

Seq Age Sex Outcome Treatment
1 76 DA Male Hospitalization| R| L ALLEGRA 180 MG AM| ANTIVERT 25 MG PM| ASPIRIN 81 MG PM| CALCIUM CITRATE + D3 VITAMIN D3 250 IU/CALCIUM 200 MG AM| DYAZIDE 25 MG/37.5 MG AM| FIBER CAPSULES 5 CAPSULES (2 G FIBER) 3X| FLOMAX 0.4 MG TWICE PER DAY| FLONASE 50 MCG NASAL SPRAY TWO SPRAYS IN EACH NOSTRIL AM| GLUCOSAMINE-CHONDROITIN 1500 MG/1200 MG TWICE PER DAY| POTASSIUM GLUCONATE 595 MG (99 MG POTASSIUM) PM